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INTRODUCTION
Subglottic hemangioma is one of the 
most common airway vascular neoplasms in 
children. It usually presents with inspiratory 
or biphasic stridor, increased by feeding and 
upper airway infections1. During its prolife-
rative stage, usually before 12 months of age, 
it can be fatal if diagnosis and treatment are 
not started quickly2.
Surgical treatment is based on tra-
cheostomy, surgical excision of the lesion, 
local injection of steroids and laser2. Recen-
tly, several authors have proposed a clinical 
management with propranolol, yielding good 
results3. The goal of the present study was 
to describe an infant with inspiratory stridor 
developed after hospitalization for acute 
viral bronchiolitis, with a final diagnosis of 
subglottic hemangioma and indication of 
clinical treatment.
CASE REPORT
An eight month-old female, with a 
history of stridor perceived by the mother, es-
pecially during sleep. She was hospitalized at 
four months of age because of an acute viral 
bronchiolitis (without findings of respiratory 
viruses). She required supplemental oxygen 
for three days and symptomatic medication. 
She was breastfed only until the fourth month 
without significant perinatal history. She had 
normal PKU test, proper weight and height 
gains, and had been properly vaccinated. The 
mother reported stridor improvements with 
oral steroids.
Upon physical examination, the infant 
was eutrophic, with mild inspiratory stridor; 
and rare transmission snoring upon pulmo-
nary auscultation. A high resolution chest CT 
scan associated with virtual bronchoscopy 
showed a vascular lesion in the subglottis, 
blocking about 90% of the airway (Figure 
1). The proposed treatment was propranolol 
(2mg/kg/day) associated with prednisolone 
(1mg/kg).
DISCUSSION
Stridor in infants may be translated 
into a wide range of conditions, some of them 
potentially life-threatening, such as subglottic 
hemangioma with airway obstruction. As 
congenital causes, we list: laryngomalacia, 
subglottic stenosis, vocal cord paralysis, laryn-
gocele and laryngeal membranes. The main 
acquired causes are foreign body aspiration, 
hemangiomas, recurrent papillomatosis and 
croup4. Hemangiomas may spontaneously 
regress later on, by 5 years of age.
Until recently, the best treatment for 
this type of condition was surgery, with re-
ports of up to 94.5% of success in some series. 
However, because of the rich vascularization 
of the lesion and its anatomical location, 
the risks inherent to the procedure should 
not be disregarded. Thus, the use of clinical 
treatment represents an important advance 
for this condition.
Monotherapy with oral steroids may 
fail in up to 75% of the patients, and it has its 
side effets6. Beta-blockers, such as proprano-
lol, may represent an inexpensive alternative, 
which is also non-invasive and well-tolerated 
by the patient4; not forgetting the paramount 
need for a cardiological assessment of the 
patient (echocardiogram and electrocardio-
gram) before treatment onset. The mechanism 
of action involved is related to the inhibition 
of mitogenic factors stimulating apoptosis 
in capillary endothelial cells. The aforemen-
tioned patient has been asymptomatic after 
one month of therapy, and will soon be off 
the steroids.
FINAL REMARKS
Treatment with propranolol is inex-
pensive, noninvasive and well tolerated, it 
may prevent the patient from being submitted 
to surgery or event tracheostomy because of 
disease progress. Such medication can cause 
bradycardia, decreased blood pressure and 
hypoglycemia. The authors’ recommenda-
tion is that once the subglottic hemangioma 
is diagnosed in children, propranolol is a 
valuable tool for treatment, pending a para-
mount cardiac evaluation prior to the start 
of medication.
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Figure 1. Chest and neck CT scan showing an angioma
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